National Health Investors, Inc. NHI

66.92 (0.24) (0.36%) as of 25 Sep
Market cap
$3.3B
P/E
19.3×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
375.63 335.18 319.84 278.19 298.72 332.81 318.08 294.61 278.66 248.46
Revenue Growth
12.07% 4.80% 14.97% (6.87%) (10.24%) 4.63% 7.97% 5.72% 12.15% 8.52%
Cost of Revenue
60.93 42.25 39.59 28.19 — — — — — —
Gross Profit
314.70 292.93 280.25 250.00 298.72 332.81 318.08 294.61 278.66 248.46
SG&A Expenses
29.53 21.79 19.82 25.32 19.34 14.56 13.91 12.86 12.71 10.20
Operating Income
195.61 183.20 177.12 81.26 133.39 223.93 217.57 204.13 197.82 161.88
Non-operating Income/Expense
(54.82) (46.56) (42.73) (15.75) (21.42) (38.62) (57.12) (49.79) (38.45) (9.16)
Non-operating Interest Expenses
57.37 59.90 58.16 44.92 50.81 52.88 56.30 49.06 46.32 43.11
EBT
140.79 136.64 134.38 65.50 111.97 185.31 160.45 154.33 159.37 152.72
Income after Tax
140.79 136.64 134.38 65.50 111.97 185.31 160.45 154.33 159.37 152.72
Dividends (Preferred)
0.20 0.12 0.06 — — — 0.00 — — 0.00
Non-Controlling Interest
(1.39) (1.35) (1.27) (0.90) 0.16 0.19 (0.01) 0.00 0.00 1.18
Net Income Common
141.98 137.87 135.60 66.40 111.80 185.13 160.46 154.33 159.37 151.54
EPS (Basic)
3.03 3.14 3.13 1.48 2.45 4.14 3.70 3.68 3.90 3.88
EPS (Diluted)
3.02 3.13 3.13 1.48 2.44 4.14 3.67 3.67 3.87 3.87
Shares (Basic, Weighted)
46.88 43.85 43.39 44.78 45.71 44.70 43.42 41.94 40.89 39.01
Shares (Diluted, Weighted)
47.05 44.10 43.39 44.79 45.73 44.70 43.70 42.09 41.15 39.16
Gross Margin
83.78% 87.39% 87.62% 89.87% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBIT Margin
52.07% 54.66% 55.38% 29.21% 44.65% 67.28% 68.40% 69.29% 70.99% 65.15%
EBT margin
37.48% 40.77% 42.02% 23.55% 37.48% 55.68% 50.44% 52.39% 57.19% 61.47%
Net Profit Margin
37.80% 41.13% 42.40% 23.87% 37.43% 55.62% 50.45% 52.39% 57.19% 60.99%
Free Cash Flow Margin
(15.30%) 16.71% 60.01% 123.40% 133.70% 46.59% 1.18% 20.44% 8.16% (76.62%)
EBITDA
281.96 261.20 251.85 163.10 218.84 312.59 299.86 279.64 270.38 224.31
EBIT
195.61 183.20 177.12 81.26 133.39 223.93 217.57 204.13 197.82 161.88
Income from Continuous Operations
140.79 136.64 134.38 65.50 111.97 185.31 160.45 154.33 159.37 152.72
Consolidated Net Income/Loss
140.79 136.64 134.38 65.50 111.97 185.31 160.45 154.33 159.37 152.72
EPS (Basic, from Continuous Ops)
3.00 3.12 3.10 1.46 2.45 4.15 3.70 3.68 3.90 3.91
EPS (Basic, Consolidated)
3.00 3.12 3.10 1.46 2.45 4.15 3.70 3.68 3.90 3.91
EPS (Diluted, from Cont. Ops)
2.99 3.10 3.10 1.46 2.45 4.15 3.67 3.67 3.87 3.90
Shares (Diluted, Average)
47.05 44.10 43.39 44.79 45.73 44.70 43.70 42.09 41.15 39.16
EPS (Diluted, Consolidated)
2.99 3.10 3.10 1.46 2.45 4.15 3.67 3.67 3.87 3.90
EBITDA Margin
75.06% 77.93% 78.74% 58.63% 73.26% 93.92% 94.27% 94.92% 97.03% 90.28%
Operating Cash Flow Margin
62.98% 61.99% 57.67% 66.62% 70.59% 69.75% 75.75% 70.56% 71.09% 71.09%

Fold the line items

In millions of $ except per-share values · columns are period end dates